From the NIH Public Access Website: The NIH Public Access Policy ensures that the public has access to the published results of NIH funded research. It requires scientists to submit final peer-reviewed journal manuscripts that arise from NIH funds to the digital archive PubMed Central upon acceptance for publication. To help advance science and improve human health, the Policy requires that these papers are accessible to the public on PubMed Central no later than 12 months after publication.
The National Institutes of Health (NIH) awarded $20 million to the University of Kentucky to move research discoveries to health care solutions more quickly. The five-year funding, awarded through the NIH's institutional Clinical and Translational Science Awards program, is the largest research funding award ever received by UK and will be used to support research at UK's Center for Clinical and Translational Science, making it part of a select national biomedical research consortium. The UK center is led by Dr.
The University of Kentucky has developed several research strengths, particularly in therapeutic areas that have high prevalence in Kentucky. These strengths include research into cancer, substance abuse, neurological diseases and cardiovascular sciences.
University of Kentucky is part of an elite group of medical centers across the country who have earned the "trifecta" of national federal funding.
Researchers at UK have discovered a new cellular mechanism that may better explain what causes amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. ALS is a neurodegenerative disease that involves the death of motor neurons, leading to the muscle weakness and atrophy.
